Naftzger J. Christopher
Insider CIK 1496194 · ABUS General Counsel and CCO · UNIS See Remarks · NBRV General Counsel and Corp Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABUS Arbutus Biopharma Corp | A Award deriv | 2025-02-14 | 2025-02-19 | 220,300 | — | $0 | 220,300 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award | 2025-02-14 | 2025-02-19 | 54,300 | — | $0 | 140,544 | SEC↗ |
| ABUS Arbutus Biopharma Corp | S Sale | 2025-02-04 | 2025-02-05 | 11,333 | $3.28 | $37.2K | 86,244 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2024-02-01 | 2024-02-05 | 380,500 | — | $0 | 380,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award | 2024-02-01 | 2024-02-05 | 95,100 | — | $0 | 95,100 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2023-07-10 | 2023-07-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 31,600 | — | $0 | 31,600 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 63,200 | — | $0 | 63,200 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 31,600 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | M Exercise deriv | 2022-08-11 | 2022-08-15 | 63,200 | — | $0 | 0 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2022-01-28 | 2022-02-01 | 63,200 | — | $0 | 63,200 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2022-01-28 | 2022-02-01 | 31,600 | — | $0 | 31,600 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2021-12-27 | 2021-12-28 | 7,000 | $0.59 | $4.1K | 7,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2021-09-30 | 2021-10-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| UNIS Unilife Corp | A Award | 2013-05-28 | 2013-05-30 | 165,000 | — | $0 | 224,440 | SEC↗ |
| UNIS Unilife Corp | A Award | 2012-03-20 | 2012-03-22 | 17,500 | — | $0 | 59,440 | SEC↗ |